why choose us

First received: June 15, 2023

Clinical Trial: A Study of LY3437943 in Participants With Impaired and Normal Liver Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Parallel-Group, Single-Dose, Phase 1, Open-Label Study to Investigate the Pharmacokinetics of LY3437943 in Participants With Hepatic Impairment Compared With Healthy Participants

Brief Summary: The main purpose of this study is to measure how much of LY3437943 gets into the bloodstream and how long it takes the body to eliminate it in participants with mild, moderate and severe impaired liver function compared to healthy participants with normal liver function.The safety and tolerability of LY3437943 will also be evaluated.The study may last up to 9 weeks for each participant including the screening period.

Read more